Jarislowsky, Fraser LTD Edwards Lifesciences Corp Transaction History

Jarislowsky, Fraser LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $182,916 - $230,241	-1,794 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $184,620 - $220,213	1,794 New	1,794 $203,000
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $260,116 - $299,755	-3,306 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $126,818 - $169,597	2,204 Added 200.0%	3,306 $228,000
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $995 - $1,539	19 Added 1.75%	1,102 $207,000
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $77,651 - $88,903	1,083 New	1,083 $252,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

Stay updated on Jarislowsky, Fraser LTD with notifications on news.